These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24963029)

  • 1. Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome.
    Boczek NJ; Ye D; Johnson EK; Wang W; Crotti L; Tester DJ; Dagradi F; Mizusawa Y; Torchio M; Alders M; Giudicessi JR; Wilde AA; Schwartz PJ; Nerbonne JM; Ackerman MJ
    Circ Res; 2014 Aug; 115(4):460-9. PubMed ID: 24963029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.
    Giudicessi JR; Ye D; Tester DJ; Crotti L; Mugione A; Nesterenko VV; Albertson RM; Antzelevitch C; Schwartz PJ; Ackerman MJ
    Heart Rhythm; 2011 Jul; 8(7):1024-32. PubMed ID: 21349352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-Regulation of K
    Clatot J; Neyroud N; Cox R; Souil C; Huang J; Guicheney P; Antzelevitch C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.
    Nakajima T; Wu J; Kaneko Y; Ashihara T; Ohno S; Irie T; Ding WG; Matsuura H; Kurabayashi M; Horie M
    Circ J; 2012; 76(12):2763-72. PubMed ID: 22987075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of the Voltage-Gated K+ Channel β2 Subunit in a Familial Case of Brugada Syndrome.
    Portero V; Le Scouarnec S; Es-Salah-Lamoureux Z; Burel S; Gourraud JB; Bonnaud S; Lindenbaum P; Simonet F; Violleau J; Baron E; Moreau E; Scott C; Chatel S; Loussouarn G; O'Hara T; Mabo P; Dina C; Le Marec H; Schott JJ; Probst V; Baró I; Marionneau C; Charpentier F; Redon R
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.
    You T; Mao W; Cai B; Li F; Xu H
    Int J Mol Med; 2015 Jul; 36(1):309-15. PubMed ID: 26016905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation.
    Olesen MS; Refsgaard L; Holst AG; Larsen AP; Grubb S; Haunsø S; Svendsen JH; Olesen SP; Schmitt N; Calloe K
    Cardiovasc Res; 2013 Jun; 98(3):488-95. PubMed ID: 23400760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for
    Ye D; Zhou W; Hamrick SK; Tester DJ; Kim CSJ; Barajas-Martinez H; Hu D; Giudicessi JR; Antzelevitch C; Ackerman MJ
    Circ Genom Precis Med; 2022 Oct; 15(5):e003238. PubMed ID: 35861988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of genes encoding for the transient outward current (Ito) identifies the KCND2 gene as a cause of J-wave syndrome associated with sudden cardiac death.
    Perrin MJ; Adler A; Green S; Al-Zoughool F; Doroshenko P; Orr N; Uppal S; Healey JS; Birnie D; Sanatani S; Gardner M; Champagne J; Simpson C; Ahmad K; van den Berg MP; Chauhan V; Backx PH; van Tintelen JP; Krahn AD; Gollob MH
    Circ Cardiovasc Genet; 2014 Dec; 7(6):782-9. PubMed ID: 25214526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.
    Delpón E; Cordeiro JM; Núñez L; Thomsen PE; Guerchicoff A; Pollevick GD; Wu Y; Kanters JK; Larsen CT; Hofman-Bang J; Burashnikov E; Christiansen M; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2008 Aug; 1(3):209-18. PubMed ID: 19122847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kv4.3-Encoded Fast Transient Outward Current Is Presented in Kv4.2 Knockout Mouse Cardiomyocytes.
    Liu J; Kim KH; Morales MJ; Heximer SP; Hui CC; Backx PH
    PLoS One; 2015; 10(7):e0133274. PubMed ID: 26196737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Roles of Xirp Proteins in Cardiac Conduction and Their Rare Variants Identified in Sudden Unexplained Nocturnal Death Syndrome and Brugada Syndrome in Chinese Han Population.
    Huang L; Wu KH; Zhang L; Wang Q; Tang S; Wu Q; Jiang PH; Lin JJ; Guo J; Wang L; Loh SH; Cheng J
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29306897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells.
    Zhang R; Jie LJ; Wu WY; Wang ZQ; Sun HY; Xiao GS; Wang Y; Li YG; Li GR
    Eur J Pharmacol; 2019 Jun; 853():74-83. PubMed ID: 30880181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
    Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN1Bβ mutations that affect their association with Kv4.3 underlie early repolarization syndrome.
    Yao H; Fan J; Cheng YJ; Chen XM; Ji CC; Liu LJ; Zheng ZH; Wu SH
    J Cell Mol Med; 2018 Nov; 22(11):5639-5647. PubMed ID: 30160358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the transient outward current (Ito) in rat cardiac myocytes and human Kv4.3 channels by mefloquine.
    Perez-Cortes EJ; Islas AA; Arevalo JP; Mancilla C; Monjaraz E; Salinas-Stefanon EM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):203-12. PubMed ID: 26216464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes induces subendocardium-predominant reduction in transient outward K+ current with downregulation of Kv4.2 and KChIP2.
    Sato T; Kobayashi T; Kuno A; Miki T; Tanno M; Kouzu H; Itoh T; Ishikawa S; Kojima T; Miura T; Tohse N
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1054-65. PubMed ID: 24486512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial Infarction.
    Liu X; Zhang Y; Du W; Liang H; He H; Zhang L; Pan Z; Li X; Xu C; Zhou Y; Wang L; Qian M; Liu T; Yin H; Lu Y; Yang B; Shan H
    Cell Physiol Biochem; 2016; 39(1):102-14. PubMed ID: 27322747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.